Over-the-counter analgesics in cirrhotic patients: a case-control study examining the risk of hospitalization for liver-associated events

References

• Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364–72.
   PubMed Web of Science ®Google Scholar
• Prescott LF. Paracetamol overdosage: pharmacological considerations and clinical management. Drugs 1983;25:290–314.
   PubMed Web of Science ®Google Scholar
• Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily. JAMA 2006;296:87–93.
   PubMed Web of Science ®Google Scholar
• Schenker S, Martin RR, Hoyumpa AM. Antecedent liver disease and drug toxicity. J Hepatol 1999;31:1098–105.
   PubMed Web of Science ®Google Scholar
• Licht H, Seeff LB, Zimmerman HJ. Apparent potentiation of acetaminophen hepatotoxicity by alcohol. Ann Intern Med 1980;92:511.
   PubMed Web of Science ®Google Scholar
• Seeff LB, Cuccherina BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399–404.
   PubMed Web of Science ®Google Scholar
• Wooton FT, Lee WM. Acetaminophen hepatotoxicity in the alcoholic. South Med J 1990;83:1047–9.
   PubMed Web of Science ®Google Scholar
• Kumar S, Rex DK. Failure of physicians to recognize acetaminophen hepatotoxicity in chronic alcoholics. Ann Intern Med 1991;151:1189–91.
   Google Scholar
• Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845–50.
   PubMed Web of Science ®Google Scholar
• Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995;22:767–73.
   PubMed Web of Science ®Google Scholar
• Heard K, Green JL, Bailey E, Bogdan GM, Dart RC. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther 2007;26:283–90.
   PubMed Web of Science ®Google Scholar
• Riley TR, Smith JP. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series. Am J Gastroenterol 1998;93:1563–5.
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994;154:311–6.
   PubMedGoogle Scholar
• Mok MY, Ng WL, Yuen MF, Wong RW, Lau CS. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 2000;18:363–8.
   PubMed Web of Science ®Google Scholar
• Tolman KG. Hepatotoxicity of non-narcotic analgesics. Am J Med 1998;105:13S–19S.
   PubMedGoogle Scholar
• Claria J, Kent JD, Lopez-Parra M, Escolar G, Ruiz-Del-Arbol L, Gines P, Effects of celecoxib and naproxen on renal function in non-azotemic patients with cirrhosis and ascites. Hepatology 2005;41:579–87.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Gines P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidsal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med 1986;24:104–22.
   Google Scholar
• Zipser RD. Role of renal prostaglandins and the effects of nonsteroidal anti-inflammatory drugs in patients with liver disease. Am J Med 1986;25:95–103.
   Google Scholar
• Roberts MS, Rumble RH, Wanwimolruk S, Thomas D, Brooks PM. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease. Eur J Clin Pharmacol 1983;25:253–61.
   PubMed Web of Science ®Google Scholar
• Sobell LC and Sobell MB. Timeline Follow-back: a technique for assessing self-reported alcohol consumption. In: Allen J, Litten RZ, editors. Measuring alcohol consumption: psychosocial and biological methods. Totowa (NJ): Humana Press, 1992: pp. 41–72.
   Google Scholar
• Khalid SK, Lane J, Navarro V, Garcia-Tsao G. Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol 2009;7:994–9.
   PubMed Web of Science ®Google Scholar
• Rossi S, Assis DN, Awsare M, Marubini E. Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendations. Drug Saf 2008;31:261–70.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903–9.
   PubMed Web of Science ®Google Scholar
• Vakili S, Sobell LC, Sobell MB, Simco ER, Agrawal S. Using the Timeline Followback to determine time windows representative of annual alcohol consumption with problem drinkers. Addict Behav 2008;33:1123–30.
   PubMed Web of Science ®Google Scholar
• Roy M, Dum M, Sobell LC, Sobell MB, Simco ER, Manor H, Comparison of the quick drinking screen and the alcohol timeline followback with outpatient alcohol abusers. Subst Use Misuse 2008;43:2116–23.
   PubMed Web of Science ®Google Scholar
• Duhig AM, Cavallo DA, McKee SA, George TP, Krishnan-Sarin S. Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav 2005;30:271–83.
   PubMed Web of Science ®Google Scholar
• Fals-Stewart W, O'Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000;68:134–44.
   PubMed Web of Science ®Google Scholar